Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to -$603,000.

  • Ironwood Pharmaceuticals' Other Working Capital Changes fell 68.91% to -$603,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year decrease of 55.89%. This contributed to the annual value of -$2.2 million for FY2024, which is 48.44% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Other Working Capital Changes is -$603,000, which was down 3.25% from -$584,000 recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Other Working Capital Changes peaked at $3.7 million during Q1 2023, and registered a low of -$6.1 million during Q4 2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$572,000 (2025), whereas its average is -$741,364.
  • In the last 5 years, Ironwood Pharmaceuticals' Other Working Capital Changes surged by 859.63% in 2023 and then crashed by 722.54% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$476,000 in 2021, then slumped by 245.80% to -$1.6 million in 2022, then tumbled by 270.66% to -$6.1 million in 2023, then grew by 28.62% to -$4.4 million in 2024, then slumped by 68.91% to -$603,000 in 2025.
  • Its Other Working Capital Changes stands at -$603,000 for Q3 2025, versus -$584,000 for Q2 2025 and -$572,000 for Q1 2025.